BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12290377)

  • 1. How to use OCs? Readers offer insights.
    Contracept Technol Update; 1999 Sep; 20(9):105-6. PubMed ID: 12290377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The basics of OCs: your peers share insights.
    Contracept Technol Update; 2000 Sep; 21(9):109. PubMed ID: 12296242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pills remain the top choice among reversible contraceptive options.
    Contracept Technol Update; 1999 Sep; 20(9):97-101. PubMed ID: 12290380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pill won't budge from no. 1 spot: half of women leave exams with OCs.
    Contracept Technol Update; 2000 Sep; 21(9):101-4. PubMed ID: 12296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pill power: oral contraceptives hold top spot in family planning arsenal.
    Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Sunday-start" OC regimen popular but may pose risk.
    Contracept Technol Update; 1991 Mar; 12(3):33-6. PubMed ID: 12283748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On 7/7/7 preferred for new patients by 47% of respondents.
    Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptives and teens: what are the options?
    Contracept Technol Update; 2000 Sep; 21(9):109-11. PubMed ID: 12296243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experts debate pill switching to combat noncompliance. Special report: annual pill survey.
    Contracept Technol Update; 1992 Oct; 13(10):149-53. PubMed ID: 12344722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey report: Guatemala.
    Owens L
    Popul Today; 1988 Sep; 16(9):5. PubMed ID: 12315801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing OCs without exam may be better for some teens.
    Contracept Technol Update; 1990 Nov; 11(11):161-4. PubMed ID: 12283377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized instructions urged for OCs.
    FDA Med Bull; 1992 Sep; 22(2):6-7. PubMed ID: 12343902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No over-the-counter OCs, say family planners.
    Contracept Technol Update; 1998 Oct; 19(10):128. PubMed ID: 12321843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examine use of low- and lower-dose OCs.
    Contracept Technol Update; 2000 Jun; 21(6):72-3. PubMed ID: 12295925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instructions for combined pill users.
    Reese M; Hatcher RA
    Contracept Technol Update; 1985 Jan; 6(1):19-20. PubMed ID: 12279914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing the use of the progestin minipill.
    Contracept Technol Update; 1999 Feb; 20(2):19-21. PubMed ID: 12294591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experts recommend ways to combat noncompliance. Special report: annual pill survey.
    Contracept Technol Update; 1992 Oct; 13(10):156-8. PubMed ID: 12344724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches vary in managing the over-40 pill patient.
    Contracept Technol Update; 1988 Sep; 9(9):105-7. PubMed ID: 12342192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headaches: OCs are "guilty by association".
    Contracept Technol Update; 1993 Jul; 14(7):109-12. PubMed ID: 12286998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians cautious in prescribing OCs for patients age 40 and over.
    Contracept Technol Update; 1987 Sep; 8(9):114-7. PubMed ID: 12268912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.